A 56-Week Extension to a Clinical Study to Assess the Efficacy and Safety of Vildagliptin Compared to Placebo in Drug Naive Patients With Type 2 Diabetes and Mild Hyperglycemia

PHASE3CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

February 20, 2006

Primary Completion Date

June 26, 2007

Study Completion Date

June 26, 2007

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Vildagliptin

Trial Locations (1)

Investigative Sites